EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect

Amina Nasri, Ikram Sghaier, Anis Neji, Alya Gharbi, Youssef Abida, Saloua Mrabet, Amina Gargouri, Mouna Ben Djebara, Imen Kacem, Riadh Gouider

Journal of Movement Disorders · 30.04.2024 · 17 (2) · 158-170

DOI: 10.14802/jmd.23178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Movement Disorders, erschienen am 30.04.2024. Verfasst von Amina Nasri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, LR18SP03, Razi University Hospital, Tunis, Tunisia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder encompassing several phenotypes with various motor and cognitive deficits. We aimed to study motor and cognitive characteristics across PSP phenotypes and to assess the influence of apolipoprotein E (APOE) gene variants on PSP phenotypic expression.

Methods

In this 20-year cross-sectional study, we retrospectively reviewed the charts of all patients classified as PSP patients and recategorized them according to phenotype using the Movement Disorder Society criteria (2017). Phenotypes were divided into three subgroups, Richardson’s syndrome (PSP-RS), PSP-cortical (PSP with predominant frontal presentation [PSP-F] + PSP with predominant speech/language disorder [PSP-SL] + PSP with predominant corticobasal syndrome [PSP-CBS]) and PSP-subcortical (PSP with predominant parkinsonism [PSP-P] + PSP with progressive gait freezing [PSP-PGF] + PSP with predominant postural instability [PSP-PI] + PSP with predominant ocular motor dysfunction [PSP-OM] + PSP with cerebellar ataxia [PSP-C] + PSP with primary lateral sclerosis [PSP-PLS]), based on clinical presentation during the first 3 years after symptom onset, which defines the early disease stage. Clinical and neuropsychological assessment data were collected. Genotyping of APOE was performed using restriction fragment length polymorphism polymerase chain reaction and verified by Sanger sequencing.

Results

We included 112 PSP patients comprising 10 phenotypes classified into 48 PSP-RS, 34 PSP-cortical (PSP-CBS, 17.6%; PSP-F, 9.4%; PSP-SL, 8.2%) and 30 PSP-subcortical (PSP-P, 11.6%; PSP-PI, 8%; PSP-OM, 2.7%; PSP-PGF, 1.8%; PSP-C, 1.8%; PSP-PLS, 0.9%) subgroups. PSP-RS patients were older at disease onset (p = 0.009) and had more akinetic-rigid and levodopa-resistant parkinsonism (p = 0.006), while PSP-cortical patients had more tremors and asymmetric and/or levodopa-responsive parkinsonism (p = 0.025). Cognitive domains were significantly less altered in the PSP-subcortical subgroup. Overall, PSP-APOEε4 carriers developed parkinsonism earlier (p = 0.038), had earlier oculomotor dysfunction (p = 0.052) and had more altered cognitive profiles. The APOEε4 allele was also associated with a younger age of parkinsonism onset in the PSP-RS phenotype group (p = 0.026).

Conclusion

This study demonstrated the wide phenotypic spectrum of PSP among Tunisians. Disease onset and akinetic-rigid and levodopa-resistant parkinsonism were the hallmarks of the PSP-RS phenotype, while milder cognitive impairment was characteristic of the PSP-subcortical subgroup. The APOEε4 allele was associated with earlier parkinsonism and oculomotor dysfunction and seemed to play a role in defining a more altered cognitive profile in PSP patients.

Schlagwörter

Stichwörter der Autor:innen

CognitionCorticalParkinsonismPhenotypesProgressive supranuclear palsySubcorticalTauopathy

Autor:innen und Institutionen

  • Department of Neurology, LR18SP03, Razi University Hospital, Tunis, Tunisia.
  • Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Clinical Investigation Center (CIC) "Neurosciences and Mental Health", Razi University Hospital, Tunis, Tunisia.

Zitieren

APA

Nasri, A., Sghaier, I., Neji, A., Gharbi, A., Abida, Y., Mrabet, S., Gargouri, A., Djebara, M. B., Kacem, I., & Gouider, R. (2024). Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect. Journal of Movement Disorders, 17(2), 158-170. https://doi.org/10.14802/jmd.23178

Vancouver

Nasri A, Sghaier I, Neji A, Gharbi A, Abida Y, Mrabet S, et al. Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect. Journal of Movement Disorders. 2024;17(2):158-170. doi:10.14802/jmd.23178

BibTeX
@article{Nasri2024,
  author = {Nasri, Amina and Sghaier, Ikram and Neji, Anis and Gharbi, Alya and Abida, Youssef and Mrabet, Saloua and Gargouri, Amina and Djebara, Mouna Ben and Kacem, Imen and Gouider, Riadh},
  title = {Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect},
  journal = {Journal of Movement Disorders},
  year = {2024},
  volume = {17},
  number = {2},
  pages = {158--170},
  doi = {10.14802/jmd.23178}
}
Kostenlos starten →